Literature DB >> 12161211

Genetic animal models for retinal degeneration.

Sascha Fauser1, Janina Luberichs, Frank Schüttauf.   

Abstract

Inherited retinal degenerations are a common cause of blindness in Western countries. A mechanism for most retinal degenerations is still unknown; hence, a suitable treatment for most of these diseases has yet to be found. Before one can rationally design a treatment, it is necessary to understand the pathway from a gene mutation to the phenotype in patients. Animal models are crucial to understand this process and to develop a treatment. Some naturally occurring animal models are known. However, over the past few years, transgenic engineering has allowed the generation of a rapidly growing number of animal models. In this review, we give an overview of the broad variety of genetic animal models for retinal degeneration.

Entities:  

Mesh:

Year:  2002        PMID: 12161211     DOI: 10.1016/s0039-6257(02)00314-4

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration.

Authors:  Matthew M LaVail; Shimpei Nishikawa; Roy H Steinberg; Muna I Naash; Jacque L Duncan; Nikolaus Trautmann; Michael T Matthes; Douglas Yasumura; Cathy Lau-Villacorta; Jeannie Chen; Ward M Peterson; Haidong Yang; John G Flannery
Journal:  Exp Eye Res       Date:  2017-11-06       Impact factor: 3.467

2.  Longitudinal assessment of retinal structure and function reveals a rod-cone degeneration in a guinea pig model initially presented as night blind.

Authors:  Julie Racine; Sandrine Joly; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2011-06-08       Impact factor: 2.379

3.  Retinal compensatory changes after light damage in albino mice.

Authors:  Luis Montalbán-Soler; Luis Alarcón-Martínez; Manuel Jiménez-López; Manuel Salinas-Navarro; Caridad Galindo-Romero; Fabrízio Bezerra de Sá; Diego García-Ayuso; Marcelino Avilés-Trigueros; Manuel Vidal-Sanz; Marta Agudo-Barriuso; Maria P Villegas-Pérez
Journal:  Mol Vis       Date:  2012-03-24       Impact factor: 2.367

Review 4.  Translating CRISPR-Cas Therapeutics: Approaches and Challenges.

Authors:  Lavina Sierra Tay; Nathan Palmer; Rebecca Panwala; Wei Leong Chew; Prashant Mali
Journal:  CRISPR J       Date:  2020-08

5.  A Mouse Model with Ablated Asparaginase and Isoaspartyl Peptidase 1 (Asrgl1) Develops Early Onset Retinal Degeneration (RD) Recapitulating the Human Phenotype.

Authors:  Pooja Biswas; Anne Marie Berry; Qais Zawaydeh; Dirk-Uwe G Bartsch; Pongali B Raghavendra; J Fielding Hejtmancik; Naheed W Khan; S Amer Riazuddin; Radha Ayyagari
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.